Literature DB >> 16222452

18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.

Yoichi Kamiyama1, Ryuusuke Aihara, Toshihiro Nakabayashi, Erito Mochiki, Takayuki Asao, Hiroyuki Kuwano, Nobuo Oriuchi, Keigo Endo.   

Abstract

The malignant potential of gastrointestinal stromal tumors (GISTs) is difficult to diagnose before surgery because the diagnoses are based on tumor diameter and mitotic index. The progression of small GISTs is always observed because they do not seem to have malignant potential. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a useful technique for assessing tumor activity. The objective of this study was to determine if FDG-PET is useful for predicting the malignant potential of gastric GISTs. Ten patients diagnosed with gastric GISTs participated. FDG-PET was performed on all of them before tumor resection. A whole-body image was initiated 40 minutes after the injection of 275 to 370 MBq FDG. FDG uptake was assessed by a standardized uptake value. All tumors had FDG uptake. There was a significant correlation between the FDG uptake and both the Ki67 index and the mitotic index but not the tumor diameter. The FDG uptake and malignant potential of gastric GISTs had a significant correlation. FDG-PET may be of considerable value for predicting the malignant potential of gastric GISTs before surgery. A gastric GIST with a high FDG uptake should be regarded as having malignant potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222452     DOI: 10.1007/s00268-005-0045-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology.

Authors:  T Inoue; N Oriuchi; M Kunio; K Tomiyoshi; Y Tomaru; K Aoyagi; S Amano; H Suzuki; J Aoki; T Sato; K Endo
Journal:  Nucl Med Commun       Date:  1999-09       Impact factor: 1.690

3.  Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours.

Authors:  T Seidal; H Edvardsson
Journal:  Histopathology       Date:  1999-05       Impact factor: 5.087

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach.

Authors:  N A C S Wong; R Young; R D G Malcomson; A G Nayar; L A Jamieson; V E Save; F A Carey; D H Brewster; C Han; A Al-Nafussi
Journal:  Histopathology       Date:  2003-08       Impact factor: 5.087

6.  Clinical management of gastrointestinal stromal tumors: before and after STI-571.

Authors:  Ronald P Dematteo; Michael C Heinrich; Wa'el M El-Rifai; George Demetri
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

7.  Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation.

Authors:  M Miettinen
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

8.  Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.

Authors:  J V Vitola; D Delbeke; M P Sandler; M G Campbell; T A Powers; J K Wright; W C Chapman; C W Pinson
Journal:  Am J Surg       Date:  1996-01       Impact factor: 2.565

9.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.

Authors:  Tadashi Hasegawa; Yoshihiro Matsuno; Tadakazu Shimoda; Setsuo Hirohashi
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

View more
  28 in total

1.  [¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case.

Authors:  Hubert H Chuang; Ferhat Deniz; Kanishka Sircar; Camilo Jimenez; Carlos Rubin De Celis; Christopher G Wood; Mouhammed Amir Habra
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  PET and PET/CT in gastrointestinal stromal tumours: the unanswered questions and the potential newer applications.

Authors:  Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-18       Impact factor: 9.236

3.  The predictive value of preoperative 18F-fluorodeoxyglucose PET for postoperative recurrence in patients with localized primary gastrointestinal stromal tumour.

Authors:  Kanae Kawai Miyake; Yuji Nakamoto; Yoshiki Mikami; Shiro Tanaka; Tatsuya Higashi; Eiji Tadamura; Tsuneo Saga; Shunsuke Minami; Kaori Togashi
Journal:  Eur Radiol       Date:  2016-02-06       Impact factor: 5.315

4.  Gastrointestinal stromal tumours (GISTs): an insight into clinical practice with review of literature.

Authors:  M J McDonnell; S Punnoose; Y K S Viswanath; N J Wadd; A Dhar
Journal:  Frontline Gastroenterol       Date:  2016-07-19

5.  Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors.

Authors:  Kozo Yoshikawa; Mitsuo Shimada; Nobuhiro Kurita; Hirohiko Sato; Takashi Iwata; Shinya Morimoto; Tomohiko Miyatani; Hideya Kashihara; Chie Takasu; Noriko Matsumoto
Journal:  Surg Today       Date:  2012-11-11       Impact factor: 2.549

Review 6.  FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.

Authors:  Philipp Malle; Manfred Sorschag; Hans-Jürgen Gallowitsch
Journal:  Wien Med Wochenschr       Date:  2012-08-14

7.  Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases.

Authors:  Tetsuro Ohno; Kyoichi Ogata; Norimichi Kogure; Hiroyuki Ando; Ryuusuke Aihara; Erito Mochiki; Hiroaki Zai; Akihiko Sano; Toshihide Kato; Shinji Sakurai; Tetsunari Oyama; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

8.  Single-incision laparoscopic surgery for a small-intestinal gastrointestinal stromal tumor: report of a case.

Authors:  Makoto Sakai; Wataru Wada; Shintaro Kimura; Akiko Okada; Tomoko Hirakata; Ryoichi Onozato; Kana Saito; Koji Morohara; Hidenobu Osawa; Kazuhisa Katayama; Naokuni Yasuda; Shigebumi Tanaka; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2014 Jul-Aug

Review 9.  A guide for the diagnosis and management of gastrointestinal stromal cell tumors.

Authors:  Paul S Sepe; William R Brugge
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04-14       Impact factor: 46.802

Review 10.  Get the GIST? An overview of gastrointestinal stromal tumours.

Authors:  G A Watson; D Kelly; M Melland-Smith; J Gleeson; G McEntee; C M Kelly; J A McCaffrey
Journal:  Ir J Med Sci       Date:  2016-02-01       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.